Profile data is unavailable for this security.
About the company
Bio-Works Technologies AB is a Sweden-based biotechnology company. The Company designs, develops, manufactures and supplies products for purification and separation of proteins and other molecules for application in areas such as Research and Laboratory, Life Science and Biopharma, as well as Food and Beverage. The Company uses technology based on uses Agarose beads, which are derived from seaweed in the process of liquid chromatography and serve as adsorbers that bind molecules of interest allowing them to be recovered. Its product offerings, marketed under brand names WorkBeads, BabyBio and OptioBio, include Activated Resin for coupling ligands, BabyBio Columns for rapid protein purification and condition screening, Immobilized Metal-ion Affinity Chromatography (IMAC) Resin, Ion Exchange Chromatography (IEX) Resin and OptioBio Glass Columns for small-scale purification and screening, among others.
- Revenue in SEK (TTM)43.90m
- Net income in SEK-56.82m
- Incorporated2013
- Employees38.00
- LocationBio-Works Technologies ABVirdings alle 18UPPSALA 754 50SwedenSWE
- Phone+46 856267430
- Fax+46 812451329
- Websitehttps://www.bio-works.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dextech Medical AB | 0.00 | -4.53m | 78.01m | 1.00 | -- | 2.52 | -- | -- | -0.2449 | -0.2449 | 0.00 | 1.67 | -- | -- | -- | -- | -- | -28.96 | -- | -29.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.89 | -- | 0.412 | -- |
| Peptonic Medical AB | 39.05m | -45.25m | 81.38m | 37.00 | -- | 0.3277 | -- | 2.08 | -0.025 | -0.025 | 0.0222 | 0.0323 | 0.4185 | 1.42 | 5.49 | 1,055,432.00 | -48.49 | -46.02 | -61.53 | -60.85 | 44.34 | 54.26 | -115.88 | -139.38 | 0.5002 | -140.41 | 0.2084 | -- | -14.93 | 149.65 | -15.55 | -- | 27.15 | -- |
| Ziccum AB | 6.64m | -20.50m | 87.62m | 9.00 | -- | 6.68 | -- | 13.21 | -1.46 | -1.46 | 0.4721 | 0.8534 | 0.2696 | -- | 22.01 | 829,375.00 | -83.29 | -68.51 | -106.42 | -76.47 | -- | -- | -308.94 | -2,598.03 | -- | -- | 0.0516 | -- | -- | 75.20 | 25.62 | -- | -13.45 | -- |
| Sprint Bioscience AB | 68.36m | 8.77m | 89.93m | 36.00 | 10.26 | 3.64 | 9.64 | 1.32 | 0.1256 | 0.1256 | 0.9791 | 0.3538 | 1.58 | -- | 11.45 | 2,441,286.00 | 20.29 | -71.22 | 43.20 | -113.71 | 80.06 | 62.75 | 12.83 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Biosergen AB | 0.00 | -27.04m | 90.76m | 4.00 | -- | 13.25 | -- | -- | -0.3475 | -0.3475 | 0.00 | 0.0247 | 0.00 | -- | -- | 0.00 | -131.31 | -- | -217.09 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.25 | -- | -- | -- |
| AroCell AB (publ) | 44.79m | -56.13m | 101.59m | -- | -- | 0.6634 | -- | 2.27 | -0.2437 | -0.2437 | 0.1944 | 0.6648 | 0.2325 | 5.82 | 5.63 | -- | -29.14 | -29.25 | -31.00 | -31.37 | 1.88 | -9.85 | -125.33 | -231.19 | 5.16 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
| Bio-Works Technologies AB | 43.90m | -56.82m | 106.03m | 38.00 | -- | 2.41 | -- | 2.42 | -1.58 | -1.58 | 1.22 | 1.13 | 0.571 | 1.82 | 5.83 | 1,155,158.00 | -73.91 | -49.14 | -101.72 | -57.90 | 61.10 | 69.88 | -129.44 | -168.30 | 2.79 | -- | 0.00 | -- | 6.23 | 46.24 | -26.41 | -- | 1.95 | -- |
| Alzinova AB | 270.00k | -16.48m | 107.35m | 5.00 | -- | 0.6268 | -- | 397.58 | -0.3385 | -0.3385 | 0.0055 | 2.07 | 0.0023 | -- | 0.3671 | 54,000.00 | -14.04 | -10.77 | -14.91 | -11.27 | 7,360.92 | -- | -6,103.69 | -18,447.90 | -- | -- | 0.007 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
| NextCell Pharma AB | 12.45m | -39.37m | 109.38m | -- | -- | 1.18 | -- | 8.79 | -0.9046 | -0.9046 | 0.286 | 1.28 | 0.1406 | 14.06 | 7.20 | -- | -44.45 | -34.92 | -50.09 | -37.06 | 12.04 | -68.21 | -316.25 | -538.60 | 4.36 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
| Odi Pharma AB (publ) | 818.38k | -3.97m | 110.35m | -- | -- | 54.19 | -- | 134.83 | -0.2608 | -0.2608 | 0.0538 | 0.1338 | 0.1084 | 1.22 | 6.98 | -- | -52.58 | -- | -95.24 | -- | -53.07 | -- | -484.96 | -- | 1.32 | -14.10 | 0.00 | -- | -55.44 | -- | 4.67 | -- | -- | -- |
| Bioextrax AB publ | 1.63m | -22.16m | 110.60m | -- | -- | 6.04 | -- | 67.93 | -0.8034 | -0.8034 | 0.0588 | 0.5315 | 0.0686 | -- | 4.96 | -- | -93.29 | -86.39 | -102.02 | -110.84 | 3.62 | -- | -1,360.93 | -2,119.90 | -- | -- | 0.00 | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
| New Nordic Healthbrands AB | 537.81m | -10.17m | 113.37m | 70.00 | -- | 1.09 | -- | 0.2108 | -1.64 | -1.64 | 86.81 | 16.86 | 2.16 | 1.84 | 4.96 | 7,367,219.00 | -4.09 | 5.36 | -9.16 | 10.55 | 65.32 | 67.30 | -1.89 | 2.38 | 0.8584 | -4.44 | 0.2821 | 47.96 | 9.51 | 6.28 | -119.41 | -- | 28.36 | -- |
| Coegin Pharma AB | 0.00 | -27.98m | 113.92m | 0.00 | -- | 8.75 | -- | -- | -2.65 | -2.65 | 0.00 | 0.6403 | 0.00 | -- | -- | -- | -125.24 | -122.02 | -201.53 | -154.70 | -- | -- | -- | -28,466.75 | -- | -170.65 | 0.00 | -- | -- | -- | 20.60 | -- | -- | -- |
| Isofol Medical AB (publ) | 0.00 | -31.16m | 115.81m | 4.00 | -- | 1.03 | -- | -- | -0.1964 | -0.1964 | 0.00 | 0.6993 | 0.00 | -- | -- | 0.00 | -20.49 | -66.73 | -24.10 | -88.27 | -- | -- | -- | -1,023.62 | -- | -- | 0.00 | -- | -94.37 | -- | 76.80 | -- | -- | -- |
| StenoCare A/S | 6.25m | -25.59m | 124.26m | 9.00 | -- | 3.64 | -- | 19.89 | -1.13 | -1.13 | 0.2674 | 1.22 | 0.1285 | -- | 2.94 | -- | -52.62 | -28.16 | -70.34 | -35.47 | -- | -- | -409.55 | -371.06 | 1.04 | -5.56 | 0.2362 | -- | -16.30 | -- | -7.77 | -- | -- | -- |
| Enorama Pharma AB | 670.00k | -42.47m | 128.73m | 5.00 | -- | 5.46 | -- | 192.13 | -1.03 | -1.03 | 0.0163 | 0.4271 | 0.0184 | 0.7583 | 0.6384 | 134,000.00 | -116.48 | -73.56 | -184.45 | -104.85 | -635.07 | 43.36 | -6,338.66 | -557.42 | 0.4626 | -605.70 | 0.02 | -- | -80.17 | -23.71 | -6.15 | -- | -- | -- |
Data as of Jun 04 2024. Currency figures normalised to Bio-Works Technologies AB's reporting currency: Swedish Krona SEK
3.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rhenman & Partners Asset Management ABas of 30 Jun 2023 | 974.23k | 2.50% |
| Schroder Investment Management Ltd.as of 30 Jun 2023 | 230.00k | 0.59% |
| E. �hman J :or Fonder ABas of 29 Feb 2024 | 0.00 | 0.00% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
